MicroTip Partnership Assay (MPA)

MicroTip Partnership Assay (MPA)

MicroTip Partnership Assay (MPA)

MicroTip Partnership Assays (MPA) are validated 3rd party assays that provide the capability to offer high value, esoteric testing to physicians, clinicians, and patients.

Sales Support




Request sales information

MPAs are validated for use on MicroTip capable VITROS® Systems*, through a partnership between select, contracted Strategic Partners and a dedicated team of Ortho scientists and professionals.

MPAs utilize the User Defined Assay (UDA) Feature with 20 open chemistry channels available for programming.

VITROS® System technologies extend to MPA and UDA testing:

  • VITROS® MicroSensorTM
  • VITROS® Intellicheck®
  • VITROS® SMART Metering
*Check the Assay Application Sheets for specific VITROS® System validation information.

User Defined Assay (UDA) Guides

MicroTip Partnership Assay (MPA) – Strategic Partners

Stanbio Laboratory (EKF Diagnostics): Link

  • Beta-Hydroxybutyrate LiquiColor® Assay

Thermo Scientific: Link

  • QMS® Amikacin
  • CEDIA® Cyclosporine
  • DRI® Ecstasy
  • QMS® Everolimus
  • CEDIA® Mycophenolic Acid
  • DRI® Oxycodone
  • QMS® Tacrolimus

© Ortho Clinical Diagnostics 2018. This site is published by Ortho Clinical Diagnostics, which is solely responsible for its contents. Product availability is subject to fulfillment of regulatory requirements in each market. This site was written for healthcare professionals in the United States only. Last Modified Date: 15-05-2015 03:00